Illumina tells EU judges it and Grail were ‘used as guinea pigs’ for new referral rules
Illumina told EU judges today that the European Commission had no right to seize jurisdiction over its acquisition of cancer-testing company Grail, and ran roughshod over its procedural rights. The acquisition...To view the full article, register now.
Already a subscriber? Click here to view full article